RAB25 and cancer: Rab25 directs ligand-bound active α5β1 integrins to late endosomes and lysosomes, where, instead of degradation, the receptors undergo retrograde transport to the plasma membrane at the rear of cancer cells in a CLIC3-dependent pathway (Dozynkiewicz et al., 2012).